Deborah Kuk

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

Alexander C. Huang, Michael A. Postow, Robert J. Orlowski et al. · Nature · 2017 · 1.7K citations · Full text

Life Sciences, Immunology, Oncology +16

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

Peter J. Allen, Deborah Kuk, Carlos Fernández-del Castillo et al. · Annals of Surgery · 2016 · 495 citations · Full text

Medicine, Oncology, Surgery +17

Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma

Marcus Tan, Murray F. Brennan, Deborah Kuk et al. · Annals of Surgery · 2015 · 366 citations

Medicine, Oncology, Surgery +17

Integrated NY-ESO-1 antibody and CD8 ⁺ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Jianda Yuan, Matthew Adamow, Brian Ginsberg et al. · Proceedings of the National Academy of Sciences · 2011 · 329 citations

Life Sciences, Immunology, Oncology +17

The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma

Alexander N. Shoushtari, Rodrigo Ramella Munhoz, Deborah Kuk et al. · Cancer · 2016 · 304 citations

Medicine, Oncology, Pharmacotherapy +17